IN CANCER CLINICAL TRIALS^ADAPTATION OF DABYL REPEATABLE RADIOTHERAPY, AND REDUCE THERAPIST SETUP TIMES.

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$50,000.00
Award Year:
1985
Program:
SBIR
Phase:
Phase I
Contract:
n/a
Agency Tracking Number:
3110
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Tripos Associates, Inc.
6548 Clayton Road, St. Louis, MO, 63117
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
RICHARD CRAMER
PRINCIPAL INVESTIGATOR
(314) 647-1099
Business Contact:
() -
Research Institution:
n/a
Abstract
IN CANCER CLINICAL TRIALS^ADAPTATION OF DABYL REPEATABLE RADIOTHERAPY, AND REDUCE THERAPIST SETUP TIMES.TRIPOS IS THE LEADING SUPPLIER OF INTERACTIVE 3-D GRAPHICS-BASED MOLECULAR MODELING SOFTWARE, USED PRIMARILY IN PHARMACEUTICAL RESEARCH. IN COLLABORATION WITH JERI1, TRIPOS HAS ALSO BEEN DEVELOPING AN INTERACTIVE 3-D GRAPHICS-BASED STATISTICAL SOFTWARE PACKAGE, PROVISIONALLY KNOWN AS DABYL, WHICH HAS MANY OF THE STATE-OF-THE-ART FEATURES NCI REQUIRES FOR CANCER CLINICAL TRIALS. PHASE I WOULD EXPLORE THE FEASIBILITY OF EXTENDING DABYL'S CAPABILITIES BEYOND THOSE NEEDED FOR ITS PRIMARY MARKET, MULTIVARIATE CHEMOMETRICS 1.ADDITION OF ANALYTICAL METHODS PECULIAR TO CANCER CLINICAL TRIALS; 2.DESIGN OF A ""COMMAND MONITOR'' CAPABLE OF BUILDING AND MANIPULATING A STACK OF DYNAMIC VARIABLES, THEREBY IMPARTING A MORE S-LIKE FLAVOR TO DABYL; 3.IMPLEMENTATION OF A GENERALIZED DATABASE INTERFACE FOR DABYL; 4.DEMONSTRATION THAT DABYL CAN BE PORTED FROM VAX/VMS TO A 32-BIT SUPERMICRO.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government